Microsoft Corp: Form 10-Q/A for the period ended Dec 31, 2011
Filed with the SEC on Jan 27, 2012 and accepted by EDGAR at Jan 27, 2012, 20:04 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-10-01 to 2011-12-31 | $20.89bn | us-gaap:SalesRevenueNet |
| Revenue | 6 months2011-07-01 to 2011-12-31 | $38.26bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-10-01 to 2011-12-31 | $5.64bn | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2011-07-01 to 2011-12-31 | $9.41bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2011-10-01 to 2011-12-31 | $2.37bn | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2011-07-01 to 2011-12-31 | $4.70bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2011-10-01 to 2011-12-31 | $7.99bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2011-07-01 to 2011-12-31 | $15.20bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-10-01 to 2011-12-31 | $95.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2011-07-01 to 2011-12-31 | $189.0m | us-gaap:InterestExpense |
| Income tax | 3 months2011-10-01 to 2011-12-31 | $1.61bn | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2011-07-01 to 2011-12-31 | $3.18bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-10-01 to 2011-12-31 | $6.62bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2011-07-01 to 2011-12-31 | $12.36bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-10-01 to 2011-12-31 | $0.78 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2011-07-01 to 2011-12-31 | $1.46 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-10-01 to 2011-12-31 | $0.79 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2011-07-01 to 2011-12-31 | $1.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2011-10-01 to 2011-12-31 | 8,465,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2011-07-01 to 2011-12-31 | 8,489,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2011-10-01 to 2011-12-31 | $5.86bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 6 months2011-07-01 to 2011-12-31 | $14.36bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2011-10-01 to 2011-12-31 | $498.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2011-07-01 to 2011-12-31 | $934.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2011-10-01 to 2011-12-31 | $1.68bn | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 6 months2011-07-01 to 2011-12-31 | $3.02bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2011-10-01 to 2011-12-31 | $1.04bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 6 months2011-07-01 to 2011-12-31 | $2.98bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2011-12-31 | $10.61bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-12-31 | $72.51bn | us-gaap:AssetsCurrent |
| Total assets | At period end2011-12-31 | $112.24bn | us-gaap:Assets |
| Current liabilities | At period end2011-12-31 | $25.37bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-12-31 | $48.12bn | us-gaap:Liabilities |
| Long-term debt | At period end2011-12-31 | $11.93bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2011-12-31 | $64.12bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-12-026864. Last ingested by Listed: Nov 13, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.